1. Home
  2. CADL vs MTLS Comparison

CADL vs MTLS Comparison

Compare CADL & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$5.04

Market Cap

357.4M

Sector

Health Care

ML Signal

HOLD

Logo Materialise NV

MTLS

Materialise NV

HOLD

Current Price

$5.01

Market Cap

311.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
MTLS
Founded
1999
1990
Country
United States
Belgium
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
357.4M
311.1M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
CADL
MTLS
Price
$5.04
$5.01
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
1.2M
85.5K
Earning Date
05-12-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
$6.38
Revenue Next Year
N/A
$6.45
P/E Ratio
N/A
$61.39
Revenue Growth
N/A
N/A
52 Week Low
$4.25
$3.93
52 Week High
$7.24
$6.80

Technical Indicators

Market Signals
Indicator
CADL
MTLS
Relative Strength Index (RSI) 49.25 44.84
Support Level $4.58 $4.94
Resistance Level $5.42 $5.44
Average True Range (ATR) 0.25 0.17
MACD 0.03 0.01
Stochastic Oscillator 70.00 35.48

Price Performance

Historical Comparison
CADL
MTLS

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About MTLS Materialise NV

Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.

Share on Social Networks: